Adicet Bio Inc
ACET
NASDAQ
Biotechnology
$8.38
USD
+0.12 (+1.45%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $77.89M
Volume 57.6K
Revenue
$0
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
$-98.97M
TTM
+16.6%
YoY
Operating Cash Flow
$-84.53M
TTM
+13.9%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
YoY Growth | — | — | — | — | — |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative | 4.0 | 5.1 | 6.9 | 4.1 | 3.9 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 32.4 | 28.0 | 31.9 | 21.6 | 22.3 |
Operating Income | -32.4 | -28.0 | -31.9 | -21.6 | -22.3 |
EBITDA | -30.7 | -26.4 | -30.4 | -20.2 | -21.1 |
Other Income / Expense | -0.2 | -0.1 | -0.1 | 0.0 | -0.1 |
Total Other Income / Expense | 1.2 | 1.1 | 1.4 | 1.3 | 1.1 |
Income Before Income Taxes | -31.2 | -26.9 | -30.5 | -20.2 | -21.2 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
Net Income | -31.2 | -26.9 | -30.5 | -20.2 | -21.4 |
Consolidated Net Income / Loss | -31.2 | -26.9 | -30.5 | -20.2 | -21.4 |
Net Income Attributable to Common Shareholders | -31.2 | -26.9 | -30.5 | -20.2 | -21.4 |
Basic EPS | -$5.48 | -$4.64 | -$2.91 | -$1.88 | -$1.99 |
Diluted EPS | -$5.48 | -$4.64 | -$2.91 | -$1.88 | -$1.99 |
Basic Shares Outstanding | 5.7M | 5.7M | 10.5M | 10.7M | 10.7M |
Diluted Shares Outstanding | 5.7M | 5.7M | 10.5M | 10.7M | 10.7M |